Pregabalin in treating challenging behaviour in patients with <scp>ID</scp>-Reference-Cited by-同舟云学术

Pregabalin in treating challenging behaviour in patients with ID

Published:2024-01 Issue:1 Volume:28 Page:3-7
ISSN:1367-7543
Container-title:Progress in Neurology and Psychiatry
language:en
Short-container-title:Prog Neurol Psychiatry

Author:

Javaid Amir¹,Adeoye Sunday²,Manivannan Geeva³

Affiliation:

1. Dr Javaid is a Consultant Psychiatrist and Honorary Senior Lecturer, at Townend Court Hull, UK.

2. Dr Adeoye is a CT2 psychiatry, at Townend Court Hull, UK.

3. Dr Manivannan is CT2 Psychiatry, at Townend Court Hull, UK.

Abstract

There is a limited but important role for pharmacological interventions (psychotropics) in the management of challenging behaviours in patients with intellectual disability. Due to limited number of psychotropics licensed for the treatment or management of challenging behaviours, this case series will further expand the horizon of research to explore the role of pregabalin in the treatment or management of complex patients with intellectual disability presenting with severe challenging behaviours.

Publisher

Wiley

Reference9 articles.

1. Challenging behaviour and learning disabilities: prevention and interventions for children with learning disabilities whose behaviour challenges: NICE guideline 2015;Tanwar M;Arch Dis Child Educ Pract Ed,2017

2. Stopping overmedication to manage challenging behaviour in LD ‐ STOMP disability – STOMP (pilot study)

3. Use of positive behaviour support plan for challenging behaviour in autism

4. National Institute for Health and Care Excellence (NICE). Challenging behaviour and learning disabilities: prevention and interventions for people with learning disabilities whose behaviour challenges. NICE guideline [NG11]. London: NICE 2015.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiple drugs;Reactions Weekly;2024-04-20